GlassScriptPhysician profile
Luis R Colato
NPI 1972713832
$15,596.64
in general payments reported to CMS, 2019-2025
36 companies · $4,557 in 2025
The $4,557 reported for 2025 was more than what 97% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $852 · 2020: $394 · 2021: $909 · 2022: $3,606 · 2023: $2,450 · 2024: $2,829 · 2025: $4,557.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,200 · Travel and Lodging: $1,636.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,200.29 |
| Travel and Lodging | $1,635.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $8,778.44 | 2021-2025 | Micra, Azure Xt Dr Mri Surescan, Aurora Ev-Icd Mri Surescan |
| Abbott Laboratories | $919.44 | 2019-2025 | Diamondback Coronary, Cardiomems, Xact |
| Novartis Pharmaceuticals Corporation | $795.81 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $628.44 | 2019-2025 | Eliquis, Camzyos |
| Abiomed | $552.94 | 2023-2025 | Impella |
| Amgen INC. | $525.42 | 2019-2025 | Repatha, Repatha |
| Bayer Healthcare Pharmaceuticals INC. | $470.36 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $355.11 | 2021-2025 | Jardiance |
| Medtronic Vascular, INC. | $270.12 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $234.29 | 2022-2023 | Farxiga |
| Boston Scientific Corporation | $219.95 | 2019-2025 | Watchman Flx, Imager II |
| Janssen Pharmaceuticals, INC | $202.96 | 2019-2024 | Xarelto |
| Cardiva Medical, INC. | $147.32 | 2024-2025 | Savvywire, Optowire, Cardiva Vascade 6/7f Vcs |
| Pfizer INC. | $138.10 | 2022-2024 | |
| Cvrx, INC. | $130.41 | 2022-2025 | Barostim Neo System |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scpharmaceuticals INC. | $124.49 | 2024-2025 | |
| Sanofi-Aventis U.S. LLC | $111.01 | 2019 | |
| Atricure, INC. | $109.99 | 2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $101.18 | 2019-2024 | Lifevest |
| Philips North America LLC | $98.29 | 2023-2025 | Ambulatory Monitoring & Diagnostics Undivided, (5091) Amb Mon & Diag Und |
| Cordis US Corp. | $91.20 | 2024 | Radial 360, S.M.A.R.T. Control |
| Actelion Pharmaceuticals US, INC. | $79.39 | 2025 | Uptravi, Opsumit |
| Edwards Lifesciences Corporation | $75.64 | 2023-2025 | |
| Cardiovascular Systems INC. | $73.14 | 2022 | |
| Impulse Dynamics (USA) INC. | $57.23 | 2024 | Optimizer |
| Regeneron Healthcare Solutions, INC. | $51.16 | 2019 | |
| Endologix LLC | $41.00 | 2023 | Alto Abdominal Stent Graft System |
| Merck Sharp & Dohme LLC | $40.37 | 2023-2025 | Verquvo |
| Stryker Corporation | $33.42 | 2025 | Artix Mt |
| Itamar Medical INC | $31.60 | 2025 | Watchpatone |
| Becton, Dickinson and Company | $25.04 | 2025 | Rotarexs 6 F X 135 Cm |
| Alnylam Pharmaceuticals INC. | $22.89 | 2025 | Amvuttra |
| Gilead Sciences, INC. | $16.99 | 2019 | |
| Esperion Therapeutics, INC. | $15.84 | 2021 | |
| Kiniksa Pharmaceuticals International, Plc | $14.47 | 2024 | Arcalyst |
| Lexicon Pharmaceuticals, INC. | $13.19 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luis Colato listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.